Results from the Children's Oncology Group phase III trial of a monoclonal antibody against the insulin-like growth factor-1 receptor in patients with newly diagnosed metastatic Ewing sarcoma.

ABSTRACT:

SUBMITTER: Carcaboso AM 

PROVIDER: S-EPMC10644028 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature